Triangle biotech startup emerges with a bang – $49M and 4 drug candidates

RESEARCH TRIANGLE PARK - Five years after launching with a team headlined by local life sciences "rainmaker" Steve Butts and $49 million in capital, Arrivo

Related Keywords

Morrisville ,North Carolina ,United States ,Michael Ackermann ,Carolina Biotechnology Center ,Jazz Pharmaceuticals ,Solas Bioventures Fund ,Stanford University ,Rex Health Ventures ,Lamassu Pharma ,Arrivo Bioventures ,Bill Wofford ,Jed Black ,Aerial Biopharma ,North Carolina Biotechnology Center ,Ireland Based Jazz Pharmaceuticals ,